Abstract

Case Report

Hypercalcaemic Crisis Associated with Hyperthyroidism: A Rare and Challenging Presentation

Karthik Baburaj*, Priya Thottiyil Nair, Abeed Hussain and Vimal MV

Published: 15 May, 2024 | Volume 8 - Issue 1 | Pages: 001-003

A 51-year-old female with a history of multinodular goitre presented with vomiting, abdominal discomfort, and generalized tiredness. Investigations revealed hypercalcemia (ionized calcium 1.41 mmol/L), hypokalaemia, suppressed parathyroid hormone, and significantly elevated free thyroxine (> 7.77 ng/dL) with a suppressed thyroid-stimulating hormone level consistent with hyperthyroidism. Further, the workup confirmed Graves’ disease as the underlying aetiology. Hyperthyroidism is occasionally associated with mild to moderate hypercalcemia, but severe hypercalcemia or hypercalcaemic crisis is an extremely rare complication. Prompt recognition and treatment are crucial to prevent life-threatening complications. The patient was treated with intravenous fluids, a low-calcium diet, zoledronic acid, carbimazole, and a beta-blocker, leading to improvement in her condition. This case highlights a rare occurrence of hypercalcaemic crisis in a patient with thyrotoxicosis due to Graves’ disease. Hyperthyroidism-induced hypercalcemia requires prompt recognition and multidisciplinary management involving endocrinologists, internists, and critical care specialists to prevent potentially life-threatening complications. Healthcare providers should consider the hypercalcaemic crisis in the differential diagnosis of hypercalcemia in the context of hyperthyroidism.

Read Full Article HTML DOI: 10.29328/journal.acem.1001029 Cite this Article Read Full Article PDF

References

  1. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008 Feb;29(1):76-131. doi: 10.1210/er.2006-0043. Epub 2007 Nov 8. PMID: 17991805.
  2. Yamamoto K, Shinozaki T, Kojima H. Hyperthyroidism-associated hypercalcemic crisis: a case report and review of the literature. J Endocrinol Invest. 2021;44(3):637-642. doi:10.1007/s40618-020-01315-x
  3. Mokrysheva NG, Vlasova MA, Romanovsky AA, Pozhilenkova EA, Anisimov VN. Effect of thyroxine on calcium metabolism. Bull Exp Biol Med. 2019;167(6):739-741. doi:10.1007/s10517-019-04429-2
  4. Bilezikian JP, Brandi ML, Cusano NE, et al. Management of endocrine disease: primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. Eur J Endocrinol. 2016;174(6):R231-R250. doi:10.1530/EJE-15-0989
  5. Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG. Direct stimulation of bone resorption by thyroid hormones. J Clin Invest. 1976 Sep;58(3):529-34. doi: 10.1172/JCI108497. PMID: 182721; PMCID: PMC333209.
  6. Cardoso LF, Maciel LM, Paula FJ. The multiple effects of thyroid disorders on bone and mineral metabolism. Arq Bras Endocrinol Metabol. 2014 Jul;58(5):452-63. doi: 10.1590/0004-2730000003311. PMID: 25166035.
  7. Dhanwal DK. Thyroid disorders and bone mineral metabolism. Indian J Endocrinol Metab. 2011 Jul;15(Suppl 2):S107-12. doi: 10.4103/2230-8210.83339. PMID: 21966645; PMCID: PMC3169869.
  8. Mosekilde L, Melsen F, Bagger JP, Myhre-Jensen O, Schwartz Sorensen N. Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol (Copenh). 1977 Jul;85(3):515-25. doi: 10.1530/acta.0.0850515. PMID: 577336.
  9. Iqbal AA, Burgess EH, Gallina DL, Nanes MS, Cook CB. Hypercalcemia in hyperthyroidism: patterns of serum calcium, parathyroid hormone, and 1,25-dihydroxyvitamin D3 levels during management of thyrotoxicosis. Endocr Pract. 2003 Nov-Dec;9(6):517-21. doi: 10.4158/EP.9.6.517. PMID: 14715479.
  10. Yokomoto M, Minamoto M, Utsunomiya D, Umakoshi H, Fukuoka T, Kondo S. Hypercalcemic crisis due to primary hyperparathyroidism occurring concomitantly with Graves' disease. Intern Med. 2015;54(7):813-8. doi: 10.2169/internalmedicine.54.2605. Epub 2015 Apr 1. PMID: 25832948.
  11. Endo A, Shigemasa C, Kouchi T, Taniguchi S, Ueta Y, Yoshida A, Mashiba H. Development of hypercalcemic crisis in a Graves' hyperthyroid patient associated with central diabetes insipidus. Intern Med. 1995 Sep;34(9):924-8. doi: 10.2169/internalmedicine.34.924. PMID: 8580571.
  12. Parker KI, Loftley A, Charles C, Hermayer K. A case of apathetic thyroid storm with resultant hyperthyroidism-induced hypercalcemia. Am J Med Sci. 2013 Oct;346(4):338-40. doi: 10.1097/MAJ.0b013e31828ffcbc. PMID: 23608928.
  13. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-1421. doi: 10.1089/thy.2016.0229. Erratum in: Thyroid. 2017 Nov;27(11):1462. PMID: 27521067.
  14. Marcocci C, Bollerslev J, Khan AA, Shoback DM. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2014 Oct;99(10):3607-18. doi: 10.1210/jc.2014-1417. Epub 2014 Aug 27. PMID: 25162668.
  15. Pennisi M, Ghiandoni G, Faggiano A, Colao A. Hypercalcemic crisis: a clinical review. Calcif Tissue Int. 2019;105(1):63-74. doi:10.1007/s00223-019-00538-8
  16. Giovanella L, Treglia G, Ceriani L. Hypercalcemic crisis in a patient with hyperthyroidism due to Graves' disease. J Endocrinol Invest. 2021;44(4):933-934. doi:10.1007/s40618-020-01324-w

Figures:

Similar Articles

Recently Viewed

  • Addiction to self-strangulation: a case-report
    Aurely Ameller*, Yann Le Strat, Marion Cadranel, Celine Portalier and Caroline Dubertret Aurely Ameller*,Yann Le Strat,Marion Cadranel,Celine Portalier, Caroline Dubertret. Addiction to self-strangulation: a case-report . J Addict Ther Res. 2017: doi: 10.29328/journal.jatr.1001003; 1: 016-021
  • Nanoencapsulated Extracts from Leaves of Bauhinia forficata Link: In vitro Antioxidant, Toxicogenetic, and Hypoglycemic Activity Effects in Streptozotocin-induced Diabetic Mice
    Bárbara Verônica Cardoso de Souza, Alessandra Braga Ribeiro*, Rita de Cássia Meneses Oliveira, Julianne Viana Freire Portela, Ana Amélia de Carvalho Melo Cavalcante, Esmeralda Maria Lustosa Barros, Luís Felipe Lima Matos, Tarsia Giabardo Alves and Maria Bárbara Verônica Cardoso de Souza, Alessandra Braga Ribeiro*, Rita de Cássia Meneses Oliveira, Julianne Viana Freire Portela, Ana Amélia de Carvalho Melo Cavalcante, Esmeralda Maria Lustosa Barros, Luís Felipe Lima Matos, Tarsia Giabardo Alves, Maria. Nanoencapsulated Extracts from Leaves of Bauhinia forficata Link: In vitro Antioxidant, Toxicogenetic, and Hypoglycemic Activity Effects in Streptozotocin-induced Diabetic Mice. Arch Pharm Pharma Sci. 2024: doi: 10.29328/journal.apps.1001063; 8: 100-115
  • Oral Suspension as Versatile Galenic Formulation in Pediatry
    Mauro Luisetto*, Almukthar N, Edbey K, Mashori GR, Fiazza C, Dona’ l, Cabianca L and Latyshev O Mauro Luisetto*, Almukthar N, Edbey K, Mashori GR, Fiazza C, Dona’ l, Cabianca L, Latyshev O. Oral Suspension as Versatile Galenic Formulation in Pediatry. Arch Pharm Pharma Sci. 2024: doi: 10.29328/journal.apps.1001062; 8: 091-099
  • Modulation of Microbiota and its Impact on Depression
    Kousik Maparu* Kousik Maparu*. Modulation of Microbiota and its Impact on Depression. Arch Pharm Pharma Sci. 2024: doi: 10.29328/journal.apps.1001061; 8: 089-090
  • Experiences of Consumers on the Health Effects of Fake and Adulterated Medicines in Nigeria
    Chijioke M Ofomata, Nkiru N Ezeama and Chinelo Ezejiegu* Chijioke M Ofomata, Nkiru N Ezeama, Chinelo Ezejiegu*. Experiences of Consumers on the Health Effects of Fake and Adulterated Medicines in Nigeria. Arch Pharm Pharma Sci. 2024: doi: 10.29328/journal.apps.1001059; 8: 075-081

Read More

Most Viewed

Read More

Help ?